166
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Rapid Separation Technique for the Determination of Potential Impurities Present in Levodopa, Carbidopa, and Entacapone in Fixed Dose Combination Drug Product Using Trifunctionally Bonded Phase Ethylene Bridged Sorbent Column with Smaller Ion-Pair Reagent

, , , &

References

  • Gordin, A.; Brooks, D. J. Clinical Pharmacology and Therapeutic Use of COMT Inhibition in Parkinson’s Disease. J. Neurol. 2007, 254 (4), IV/37–IV/48.
  • Demura, N. Pharmacology and Clinical Profile of the COMT Inhibitor Entacapone as an Anti-Parkinson’s Disease Drug. Japan. Pharmacol. Therapeut. 2008, 36 (2), 155–163.
  • Juri, C. C.; Chana, C. P. Levodopa for Parkinson’s Disease. What Have We Learned? Revista Medica de Chile 2006, 134 (7), 893–901.
  • Najib, J. Entacapone: A Catechol-O-methyltransferase Inhibitor for the Adjunctive Treatment of Parkinson’s Disease. Clin. Therapeut. 2001, 23 (6), 802–832.
  • Ragab, G. H.; Elmasry, M. S.; Kheir, A. A. Spectrophotometric Determination of Some Phenolic Drugs in Pure Form and in Their Pharmaceutical Preparations. Jordan J. Pharm. Sci. 2009, 2 (1), 66–75.
  • Pagani, A. P.; Cabezon, M. A.; Ibanez, G. A. Simultaneous Kinetic-spectrofluorimetric Determination of Levodopa and Carbidopa Using Partial Least-squares Regress. Anal. Sci. 2009, 25 (5), 633–638.
  • Sima, I. A.; Casoni, D.; Sarbu, C. Simultaneous Determination of Carbidopa and Levodopa Using a New TLC Method and a Free Radical as Detection Reagent. J. Liq. Chromatogr. Rel. Technol. 2013, 36 (17), 2395–2404.
  • Gandhi, D. B.; Mehta, P. J. Simultaneous RP-HPTLC Method for Determination of Levodopa, Carbidopa, and Entacapone in Combined Tablet Dosage Form. J. Planar Chromatogr.--Modern TLC 2011, 24 (3), 236–241.
  • Khanmohammadi, M.; Mobedi, E.; Garmarudi, A. B.; Mobedi, H.; Kargosha, K. Simultaneous Determination of Levodopa and Carbidopa in Levodopa-Carbidopa Tablets by ATR-FTIR Spectrometry. Pharm. Develop. Technol. 2007, 12 (6), 573–580.
  • Talebpour, Z.; Haghgoo, S.; Shamsipur, M. 1H Nuclear Magnetic Resonance Spectroscopy Analysis for Simultaneous Determination of Levodopa, Carbidopa and Methyldopa in Human Serum and Pharmaceutical Formulations. Anal. Chim. Acta 2004, 506 (1), 97–104.
  • Cesar, I. C.; Byrro, R. M. D. S. e Silva; Cardoso, F. F.; Mundim, I. M.; Souza, T. L.; Gomes, S. A.; Bonfim, R. R.; Pianetti, G. A. Development and Validation of a High-performance Liquid Chromatography-Electrospray Ionization-MS/MS Method for the Simultaneous Quantitation of Levodopa and Carbidopa in Human Plasma. J. Mass Spectr. 2011, 46 (9), 943–948.
  • Zhang, L.; Chen, G.; Hu, Q.; Fang, Y. Separation and Determination of Levodopa and Carbidopa in Composite Tablets by Capillary Zone Electrophoresis with Amperometric Detection. Anal. Chim. Acta 2001, 431 (2), 287–292.
  • Sravanthi, D.; Anusha, M.; Madhavi, S.; Firdose, Shaik; Nalluri, Buchi N. Simultaneous Estimation of Levodopa and Carbidopa in Bulk, Pharmaceutical Dosage Forms and Dissolution Sample Analysis by RP-HPLC-PDA Method. J. Chem. Pharm. Res. 2013, 5 (11), 422–428.
  • Doshi, A. S.; Upadhyay, K. J.; Mehta, T. N.; Nanda, N. Development and Application of a High-performance Liquid Chromatographic Method for the Determination of in vitro Drug Release of Levodopa, Carbidopa, and Entacapone from a Tablet Formulation. J. AOAC Intl. 2009, 92 (2), 394–403.
  • El-Bayoumi, A. E.; Badawy, A. M.; Kafou, A.; El-Ghasem, H. Determination of Levodopa in Combined Dosage Form with Carbidopa by Spectrophotometric and HPLC Methods. Bull. Faculty Pharm. (Cairo University) 2009, 47 (3), 13–20.
  • Kumar, S. S.; Natraj, K.; Khan, A.; Kumar, B. K.; Rao, J. V. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Levodopa and Carbidopa in Pharmaceutical Dosage Forms. J. Pharm. Res. 2011, 4 (11), 4060–4062.
  • Issa, Y. M.; Hassoun, M. E. M.; Zayed, A. G. Application of High Performance Liquid Chromatographic Method for the Determination of Levodopa, Carbidopa, and Entacapone in Tablet Dosage Forms. J. Liq. Chromatogr. Rel. Technol. 2011, 34 (19), 2433–2447.
  • Shalini, S.; Ravindra, R. Y. Method Development and Validation of Levodopa and Carbidopa in a Combined Dosage Form by RP-HPLC Method. Intl. J. Pharm. Technol. 2011, 3 (3), 2943–2960.
  • Mao, W. Determination of Two Components in Carbidopa-levodopa Controlled-release Tablets by HPLC. Zhongguo Yaopin Biaozhun 2007, 8 (6), 74–76.
  • Alagar, R. M.; Ch. Shyamsunder, D. B.; Rao, K. N. V.; Selvakumar, D. Analytical Method Development and Validation for Simultaneous Estimation of Carbidopa, Levodopa and Entacapone in Its Bulk and Tablet Dosage Form by UPLC. Intl. Res. J. Pharm. 2013, 4 (11), 53–56.
  • ICH. Validation of Analytical Procedures: Text and Methodology, Q2 (R1), Geneva, Switzerland, 2005.
  • ICH. Stability Testing of New Drug Substances and Products, Q1A (R2), Geneva, Switzerland, 2005.
  • US FDA Guidance. Analytical Procedures and Methods Validation, Rockville, Maryland, 2000.
  • Official Methods of Analysis, 15th ed.; Association of Official Analytical Chemists International: Arlington, VA, 1990; XVII p.
  • Validation of Compendial Methods <1225>; The United States Pharmacopeia, 2012.
  • United States Pharmacopeial Convention, 36th ed.; The United States Pharmacopoeia: Rockville, MD, 2012.
  • Guideline for Submitting Samples and Analytical Data for Methods Validation; US Food and Drug Administration, February 1987, Rockville, Maryland.
  • Bliesner, D. M. Validating Chromatographic Methods: A Practical Guide; John Wiley & Sons, Inc.: Hoboken, New Jersey, 2006.
  • Baertschi, S. W.; Alsante, K.; Reed, R. A. Pharmaceutical Stress Testing: Predicting Drug Degradation; Informa Healthcare, London, 2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.